Dental Pulp Disease
Conditions
Brief summary
Formocresol (FC) is the most universally taught and most widely used pulpotomy medicament in the primary teeth. However, concerns have been raised over the use of FC because of its toxicity and potential carcinogenicity. A substitution for FC has been investigated but evidence is lacking to conclude which is the most appropriate technique for pulpotomies in primary teeth. Sodium hypochlorite (NaOCl) has been used in root canal irrigant for more than 80 years, and it is at present the most popular irrigant in root canal treatment. Studies have showed that NaOCl is biological compatible and is a very good antimicrobial solution without being a pulpal irritant. Recent studies using sodium hypochlorite as pulpotomy medicament in primary molars showed promising results. In this project, the investigators propose a randomized clinical trial, which will be performed in Pediatric Dentistry Department of the National Taiwan University Hospital, to compare the treatment outcomes between NaOCl and FC in human primary molars needing pulpotomy treatment. The aim of this sudy is to determining weather NaOCl is a suitable replacement for FC in the pulpotomy of human primary molar teeth. To assess this aim, 200 healthy children from 2.5 to 9 year-old, who have at least one primary first or second molars diagnosed to receive pulpotomy treatment will be recruited in this project. The involved teeth will be randomly assigned to the control group (dilute 20% Formocresol (DFC)) or experimental group (2.5% NaOCl). At 3, 6, 9, 12, 15, 18, 21 and 24 months post-treatment, the randomly assigned teeth will be clinically and radiographically evaluated by blinded independent evaluators to the treatment group. The differences will be statistically analyzed using chi-square test, Fisher exact test, and t-test, using a statistical significance at p\<0.05.
Detailed description
As Brief summary.
Interventions
PROCEDURENaOCl pulpotomy
Use 2.5% NaOCl as pulpotomy medicament for primary molars
PROCEDUREFC pulpotomy
Use 20% Formocresol as pulpotomy medicament for primary molars
DRUG2.5% NaOCl
DRUG20% Formocresol
Sponsors
National Taiwan University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
30 Months to 9 Years
Healthy volunteers
Yes
Inclusion criteria
* healthy, American Society of Anesthesiologists (ASA) Physical Status classification system class I children * age between 2.5 and 9 years old * with one or more primary molars need pulpotomy treatment
Exclusion criteria
* children younger than 2.5 or older than 9 years of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of Clinical Findings | At 3, 6, 9, 12, 15, 18, 21 and 24 months post-treatment | The outcome will be assessed first by clinical findings. We can discriminate the result are successful or not by scoring the clinical finding from 1 to 4 . Criteria for clinical scoring 1. Asymptomatic, clinical score=1 2. Slight discomfort: percussion sensitivity; mobility\>1mm but\<2mm, clinical score=2 3. Minor discomfort :long-lasting chewing sensitivity; gingival swelling; periodontal pocket formation without exudate; mobility\>2mm but\<3mm, clinical score=3 4. major discomfort: Late pathological changes; spontaneous pain; periodontal pocket formation with exudate; sinus tract; mobility≧3 mm; premature tooth loss due to pathology, clinical score=4 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of Radiographic Findings | At 3, 6, 9, 12, 15, 18, 21 and 24 months post-treatment | The outcome will be assessed then by radiographic findings. We can discriminate the result are successful or not by scoring the radiographic findings from1 to 5. Criteria for radiographic scoring 1. Dentinal bridge, clinical score=1, regeneration tissue response 2. No change, clinical score=2, no pathological changes 3. Pulp canal obliteration, clinical score=3, slight pathological changes, no clinical significance 4. Periodontal ligament widening, clinical score=3, slight pathological changes, no clinical significance 5. Internal root resorption (non-perforated), clinical score=4, minor pathological changes 6. External root resorption, clinical score=4, minor pathological changes 7. Internal root resorption (perforated), clinical score=4, minor pathological changes 8. Peri-radicular lesion, clinical score=5, major pathological changes, treatment needed |
Countries
Taiwan
Contacts
Primary ContactHsiao-Hua Chang, phD
Outcome results
None listed